I have to disagree with you on that^ .
There is nothing new in the pipeline. There are a few new atypicals (Vraylar, Latuda, Saphris, Rexahulti) - which you might be referring too. Lithium and Depakote btw have defeated these "new meds" in some areas. The "new" meds seem to be good for the depression side- however for example Latuda has as many side effects as Geodon- nothing miraculous just different options so to speak.